|
1
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
2
|
Lo WL, Kao SY, Chi LY, Wong YK and Chang
RC: Outcomes of oral squamous cell carcinoma in Taiwan after
surgical therapy: Factors affecting survival. J Oral Maxillofac
Surg. 61:751–758. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pérez-Sayáns M, Somoza-Martín JM,
Barros-Angueira F, Diz PG, Rey JM and García-García A: Multidrug
resistance in oral squamous cell carcinoma: the role of vacuolar
ATPases. Cancer Lett. 295:135–143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133(+) cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
View Article : Google Scholar
|
|
5
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Savagner P, Yamada KM and Thiery JP: The
zinc-finger protein slug causes desmosome dissociation, an initial
and necessary step for growth factor-induced epithelial-mesenchymal
transition. J Cell Biol. 137:1403–1419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kumar R, Gururaj AE and Barnes CJ:
21-activated kinases in cancer. Nat Rev Cancer. 6:459–471. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parvathy M, Sreeja S, Kumar R and Pillai
MR: Potential role of p21 activated kinase 1 (PAK1) in the invasion
and motility of oral cancer cells. BMC Cancer. 16(Suppl 1):
2932016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liao XH, Lu DL, Wang N, Liu LY, Wang Y, Li
YQ, Yan TB, Sun XG, Hu P and Zhang TC: Estrogen receptor α mediates
proliferation of breast cancer MCF-7 cells via a
p21/PCNA/E2F1-dependent pathway. FEBS J. 281:927–942. 2014.
View Article : Google Scholar
|
|
13
|
Li H, Xiang Y, Fan LJ, Zhang XY, Li JP, Yu
CX, Bao LY, Cao DS, Xing WB, Liao XH and Zhang TC: Myocardin
inhibited the gap protein connexin 43 via promoted miR-206 to
regulate vascular smooth muscle cell phenotypic switch. Gene.
616:22–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao XH, Xiang Y, Yu CX, Li JP, Li H, Nie
Q, Hu P, Zhou J and Zhang TC: STAT3 is required for
MiR-17-5p-mediated sensitization to chemotherapy-induced apoptosis
in breast cancer cells. Oncotarget. 8:15763–15774. 2017.PubMed/NCBI
|
|
15
|
Xiang Y, Lu DL, Li JP, Yu CX, Zheng DL,
Huang X, Wang ZY, Hu P, Liao XH and Zhang TC: Myocardin inhibits
estrogen receptor alpha-mediated proliferation of human breast
cancer MCF-7 cells via regulating MicroRNA expression. IUBMB Life.
68:477–487. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu Y, Chopp M, Zheng X, Katakowski M,
Buller B and Jiang F: MiR-145 reduces ADAM17 expression and
inhibits in vitro migration and invasion of glioma cells. Oncol
Rep. 29:67–72. 2013.
|
|
17
|
Liao XH, Zheng L, He HP, Zheng DL, Wei ZQ,
Wang N, Dong J, Ma WJ and Zhang TC: STAT3 regulated ATR via
microRNA-383 to control DNA damage to affect apoptosis in A431
cells. Cell Signal. 27:2285–2295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshikawa K, Noguchi K, Nakano Y, Yamamura
M, Takaoka K, Hashimoto-Tamaoki T and Kishimoto H: The Hippo
pathway transcriptional co-activator, YAP, confers resistance to
cisplatin in human oral squamous cell carcinoma. Int J Oncol.
46:2364–2370. 2015.PubMed/NCBI
|
|
19
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang M, Ren MP, Zhao L, Li CP and Deng MM:
miR-485-5p acts as a negative regulator in gastric cancer
progression by targeting flotillin-1. Am J Transl Res. 7:2212–2222.
2015.
|
|
22
|
Jing LL and Mo XM: Reduced miR-485-5p
expression predicts poor prognosis in patients with gastric cancer.
Eur Rev Med Pharmacol Sci. 20:1516–1520. 2016.PubMed/NCBI
|
|
23
|
Kim TH, Kim YK, Kwon Y, Heo JH, Kang H,
Kim G and An HJ: Deregulation of miR-519a, 153, and 485-5p and its
clinicopathological relevance in ovarian epithelial tumours.
Histopathology. 57:734–743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lou C, Xiao M, Cheng S, Lu X, Jia S, Ren Y
and Li Z: MiR-485-3p and miR-485-5p suppress breast cancer cell
metastasis by inhibiting PGC-1α expression. Cell Death Dis.
7:e21592016. View Article : Google Scholar
|
|
25
|
De Vita V Jr, Hellman S, Rosenberg S and
Markoe AM: Cancer: Principles and practice of oncology. Am J Clin
Oncol. 9:901986. View Article : Google Scholar
|
|
26
|
Birchmeier W, Hulsken J and Behrens J:
E-cadherin as an invasion suppressor. Ciba Found Symp. 189:124–141.
174–176. 1995.PubMed/NCBI
|
|
27
|
Vleminckx K, Vakaet L Jr, Mareel M, Fiers
W and van Roy F: Genetic manipulation of E-cadherin expression by
epithelial tumor cells reveals an invasion suppressor role. Cell.
66:107–119. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Woodhouse EC, Chuaqui RF and Liotta LA:
General mechanisms of metastasis. Cancer. 80(Suppl 8): 1529–1537.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang W, Feng M, Zheng G, Chen Y, Wang X,
Pen B, Yin J, Yu Y and He Z: Chemoresistance to 5-fluorouracil
induces epithelial-mesenchymal transition via up-regulation of
Snail in MCF7 human breast cancer cells. Biochem Biophys Res
Commun. 417:679–685. 2012. View Article : Google Scholar
|
|
33
|
Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee
SK, Ahn YC, Jeong HS, Son YI, Baek JH, et al: ERCC1 expression as a
predictive marker of squamous cell carcinoma of the head and neck
treated with cisplatin-based concurrent chemoradiation. Br J
Cancer. 99:167–172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
